Baloxavir treatment of oseltamivir‐resistant influenza A/H1pdm09 in two immunocompromised patients-Reference-Cited by-同舟云学术

Baloxavir treatment of oseltamivir‐resistant influenza A/H1pdm09 in two immunocompromised patients

Published:2020-12-22 Issue:3 Volume:23 Page:
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transpl. Infect. Dis.

Author:

Macesic Nenad¹²^ORCID,Laplante Jennifer M.³,Aaron Justin G.¹,DiMango Emily A.⁴,Miko Benjamin A.¹,Pereira Marcus R.¹,Reshef Ran⁵,St. George Kirsten³⁶

Affiliation:

1. Division of Infectious Diseases Columbia University Irving Medical Center New York NY USA

2. Department of Infectious Diseases The Alfred Hospital and Central Clinical SchoolMonash University Melbourne VIC Australia

3. Laboratory of Viral Diseases Wadsworth Center New York State Department of Health Albany NY USA

4. Department of Pulmonary, Allergy, and Critical Care Medicine Columbia University Irving Medical Center New York NY USA

5. Division of Hematology & Oncology Columbia University Irving Medical Center New York NY USA

6. Department of Biomedical Science University at Albany Albany NY USA

Funder

National Health and Medical Research Council

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tid.13542

Reference22 articles.

1. Recovery of Drug‐Resistant Influenza Virus from Immunocompromised Patients: A Case Series

2. Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa

3. Antiviral Resistance in Influenza Viruses

4. Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents

5. Treatment‐emergent influenza variant viruses with reduced baloxavir susceptibility: impact on clinical and virologic outcomes in uncomplicated influenza;Uehara T;J Infect Dis,2020

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Zanamivir and baloxavir combination to cure persistent influenza and coronavirus infections after hematopoietic stem cell transplant;International Journal of Antimicrobial Agents;2024-09

2. Clinical outcomes of baloxavir versus oseltamivir in immunocompromised patients;Transplant Infectious Disease;2024-02-06

3. Identification of tanshinone I as cap-dependent endonuclease inhibitor with broad-spectrum antiviral effect;Journal of Virology;2023-10-31

4. Design, synthesis and structure-activity relationship of dihydrobenzoquinolines as novel inhibitors against influenza A virus;European Journal of Medicinal Chemistry;2022-12

5. Assessing the fitness of a dual-antiviral drug resistant human influenza virus in the ferret model;Communications Biology;2022-09-28